Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic And Screening
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic And Screening Segment by Type
1.2.2 Lung Cancer Diagnostic And Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lung Cancer Diagnostic And Screening Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lung Cancer Diagnostic And Screening Market Competitive Landscape
3.1 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2019-2024)
3.2 Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Lung Cancer Diagnostic And Screening Market Size Sites, Area Served, Product Type
3.4 Lung Cancer Diagnostic And Screening Market Competitive Situation and Trends
3.4.1 Lung Cancer Diagnostic And Screening Market Concentration Rate
3.4.2 Global 5 and 10 Largest Lung Cancer Diagnostic And Screening Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.1 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Lung Cancer Diagnostic And Screening Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Lung Cancer Diagnostic And Screening Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
7 Lung Cancer Diagnostic And Screening Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Application (2019-2024)
7.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
8 Lung Cancer Diagnostic And Screening Market Segmentation by Region
8.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic And Screening Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic And Screening Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Lung Cancer Diagnostic And Screening Basic Information
9.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Overview
9.1.3 Pfizer Lung Cancer Diagnostic And Screening Product Market Performance
9.1.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.1.5 Pfizer Business Overview
9.1.6 Pfizer Recent Developments
9.2 F.Hoffmann-La Roche AG
9.2.1 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Basic Information
9.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
9.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Market Performance
9.2.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.2.5 F.Hoffmann-La Roche AG Business Overview
9.2.6 F.Hoffmann-La Roche AG Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Basic Information
9.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
9.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Market Performance
9.3.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Basic Information
9.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
9.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 AstraZeneca Plc
9.5.1 AstraZeneca Plc Lung Cancer Diagnostic And Screening Basic Information
9.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
9.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.5.4 AstraZeneca Plc Business Overview
9.5.5 AstraZeneca Plc Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Lung Cancer Diagnostic And Screening Basic Information
9.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
9.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Medtronic Plc
9.7.1 Medtronic Plc Lung Cancer Diagnostic And Screening Basic Information
9.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
9.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.7.4 Medtronic Plc Business Overview
9.7.5 Medtronic Plc Recent Developments
9.8 Danaher Corporation
9.8.1 Danaher Corporation Lung Cancer Diagnostic And Screening Basic Information
9.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
9.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.8.4 Danaher Corporation Business Overview
9.8.5 Danaher Corporation Recent Developments
9.9 Siemens Healthcare GmbH
9.9.1 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Basic Information
9.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
9.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Market Performance
9.9.4 Siemens Healthcare GmbH Business Overview
9.9.5 Siemens Healthcare GmbH Recent Developments
9.10 FUJIFILM Corporation
9.10.1 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Basic Information
9.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
9.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.10.4 FUJIFILM Corporation Business Overview
9.10.5 FUJIFILM Corporation Recent Developments
9.11 KoninklijikePhilips N.V.
9.11.1 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Basic Information
9.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
9.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Market Performance
9.11.4 KoninklijikePhilips N.V. Business Overview
9.11.5 KoninklijikePhilips N.V. Recent Developments
9.12 GE Healthcare Bio Sciences AB
9.12.1 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Basic Information
9.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
9.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Market Performance
9.12.4 GE Healthcare Bio Sciences AB Business Overview
9.12.5 GE Healthcare Bio Sciences AB Recent Developments
9.13 Quest Diagnostics lIncorporated
9.13.1 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Basic Information
9.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
9.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Market Performance
9.13.4 Quest Diagnostics lIncorporated Business Overview
9.13.5 Quest Diagnostics lIncorporated Recent Developments
9.14 Agilent Technologies lnc
9.14.1 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Basic Information
9.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
9.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Market Performance
9.14.4 Agilent Technologies lnc Business Overview
9.14.5 Agilent Technologies lnc Recent Developments
9.15 Qiagen Inc.
9.15.1 Qiagen Inc. Lung Cancer Diagnostic And Screening Basic Information
9.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
9.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.15.4 Qiagen Inc. Business Overview
9.15.5 Qiagen Inc. Recent Developments
9.16 Myriad Genetic Laboratories Inc.
9.16.1 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Basic Information
9.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
9.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.16.4 Myriad Genetic Laboratories Inc. Business Overview
9.16.5 Myriad Genetic Laboratories Inc. Recent Developments
9.17 NeoGenomics Laboratories Inc
9.17.1 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Basic Information
9.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
9.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.17.4 NeoGenomics Laboratories Inc Business Overview
9.17.5 NeoGenomics Laboratories Inc Recent Developments
9.18 Canon MedicalSystems Corporation
9.18.1 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Basic Information
9.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
9.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.18.4 Canon MedicalSystems Corporation Business Overview
9.18.5 Canon MedicalSystems Corporation Recent Developments
9.19 Eon Health Inc
9.19.1 Eon Health Inc Lung Cancer Diagnostic And Screening Basic Information
9.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
9.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.19.4 Eon Health Inc Business Overview
9.19.5 Eon Health Inc Recent Developments
10 Lung Cancer Diagnostic And Screening Regional Market Forecast
10.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast
10.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostic And Screening by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Lung Cancer Diagnostic And Screening Market Forecast by Type (2025-2030)
11.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
